Dr. Nirali P. Bhatt, MD

Dr. Bhatt practices at Perelman Center for Advanced Medicine in Philadelphia, Pennsylvania.

Dr. Bhatt's NPI, 1174758791, was assigned on May 27, 2009. Dr. Bhatt graduated from George Washington University School of Medicine in 2009. Dr. Bhatt holds Pennsylvania license MD451480.

Dr. Bhatt's primary practice is Perelman Center for Advanced Medicine, at 3400 Civic Center Blvd, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 614-4100.

Dr. Bhatt's primary practice is Perelman Center for Advanced Medicine in Philadelphia, Pennsylvania. Dr. Bhatt is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Bhatt to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhatt practices, 2 sites in all. Vendor and product names are available with a free account.

Uveitis and ocular inflammatory disease is Dr. Bhatt's primary specialty in the NPI Registry, under taxonomy code 207WX0108X. Dr. Bhatt is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Bhatt is licensed in Pennsylvania.

CMS data shows 185 Medicare services from Dr. Bhatt across 5 procedure codes in 2024, for 73 Medicare patients. Medicare paid $10,219 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Dr. Bhatt in 2024. The largest group is 65 to 74, with 35 patients. 68% of them have high blood pressure, and 68% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhatt's median patient age at 61, with 67% women.

In 2024, Dr. Bhatt wrote 207 Medicare Part D claims for 58 patients. 78% of them were for generic drugs. CMS names the drug for 166 of them, across 7 drugs with 11 or more claims each, at $12,727 in total drug cost. In 2023, CMS named 200 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Bhatt for performance year 2024, reported as part of a group. Dr. Bhatt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 33 papers to Dr. Bhatt, published from 2012 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Uveitis, Visual Acuity and Cataract Extraction. Dr. Bhatt has published most often in Ocul Immunol Inflamm. Dr. Bhatt's most frequent co-authors are James Todd Rosenbaum, MD, Eric Barton Suhler, MD and Jennifer Elizabeth Thorne, MD.

Dmand AI links Dr. Bhatt to 3 clinical trials, 3 of them phase 3 studies. Conditions studied include Uveitis, Macular Edema and Uveal Diseases. JHSPH Center for Clinical Trials sponsors the most, 3.

CMS Open Payments shows 23 general payments to Dr. Bhatt from 5 drug and device companies from 2016 to 2024. Honoraria make up the largest share, 67% of the total. Alimera Sciences, Inc. paid the most, $6,629.

Dr. Bhatt graduated from George Washington University School of Medicine in 2009.